A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

“This study reveals that this enzyme [nSMase2] is such an enzyme that the virus has evidently hijacked to use in its replication strategy.” Previous research suggested that HIV infection increased the ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

HIV-1 protease is a crucial enzyme in the life cycle of the Human Immunodeficiency Virus (HIV), and it has been a primary target for antiretroviral therapy. However, the emergence of drug ...

The enzymes have cut open the round vectors and ... You have just produced a naked-DNA HIV vaccine. Trials for a genetic vaccine that may protect against AIDS began in 1995. These vaccines ...

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...

HIV-1, the virus responsible for AIDS, relies on several key enzymes for its replication, including reverse transcriptase (RT) and integrase. Reverse transcriptase is crucial for converting the ...

A retroviral enzyme which converts genetic material from RNA into DNA, an essential step in the lifecycle of HIV. Several classes of anti-HIV drugs interfere with this stage of HIV’s life cycle: ...

Once HIV has bound to CD4, it activates other proteins on the surface of the human cell known as CCR5 and CXCR4 in order to complete its fusion with the cell. Once fusion has occurred, the inside of ...